Skip to main content

Table 2 Baseline levels of the measured markers in the total population and according to the presence of low or high RPR

From: vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease

 

Total population

Low RPR (n = 741)

High RPR (n = 258)

p-value§

vWF (%)

105 (82, 133)

100 (79, 126)

124 (94, 145)

< 0.001

ADAMTS13 antigen (ng/mL)

532 (461, 606)

537 (469, 613)

511 (448, 580)

0.001

ADAMTS13 activity (IU/mL)

1.03 (0.83, 1.19)

1.04 (0.84, 1.19)

0.99 (0.76, 1.16)

0.020

Ratio vWF/ADAMTS13 antigen

0.20 (0.15, 0.26)

0.19 (0.14, 0.25)

0.23 (0.18, 0.31)

< 0.001

Ratio vWF/ADAMTS13 activity

107 (77, 152)

101 (73, 137)

127 (93, 192)

< 0.001

Platelet count (× 109/L)

227 (195, 264)

224 (192, 261)

236 (200, 273)

0.010

  1. Values are given as median (25th, 75th percentiles)
  2. § p-values refer to differences between the groups with high or low RPR
  3. Significant p-values are highlighted with boldface